IL94525A0 - Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders - Google Patents

Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders

Info

Publication number
IL94525A0
IL94525A0 IL94525A IL9452590A IL94525A0 IL 94525 A0 IL94525 A0 IL 94525A0 IL 94525 A IL94525 A IL 94525A IL 9452590 A IL9452590 A IL 9452590A IL 94525 A0 IL94525 A0 IL 94525A0
Authority
IL
Israel
Prior art keywords
bmy
pharmaceutical compositions
degenerative brain
brain disorders
treating ischemic
Prior art date
Application number
IL94525A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL94525A0 publication Critical patent/IL94525A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IL94525A 1989-06-01 1990-05-28 Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders IL94525A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/360,658 US5055470A (en) 1989-06-01 1989-06-01 Method of treatment of ischemia in brain

Publications (1)

Publication Number Publication Date
IL94525A0 true IL94525A0 (en) 1991-03-10

Family

ID=23418925

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94525A IL94525A0 (en) 1989-06-01 1990-05-28 Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders

Country Status (8)

Country Link
US (1) US5055470A (ca)
EP (1) EP0410114A3 (ca)
JP (1) JPH0320222A (ca)
KR (1) KR910000151A (ca)
CA (1) CA2017781A1 (ca)
HU (1) HU205856B (ca)
IL (1) IL94525A0 (ca)
TW (1) TW198681B (ca)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
CA2081062A1 (en) * 1991-10-24 1993-04-25 Frank D. Yocca Treatment of anxiety in benzodiazepine-withdrawn patients
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
EP0647137B1 (en) * 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
CA2296056A1 (en) * 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
US20060052386A1 (en) * 2003-06-12 2006-03-09 Tadeusz Wieloch Sigma ligands for neuronal regeneration and functional recovery
EP1644026A4 (en) * 2003-06-12 2007-10-24 Ms Science Corp SIGMA LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RECREATION
WO2009026282A2 (en) 2007-08-21 2009-02-26 Midwestern University Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist
ES2614813T3 (es) 2009-04-30 2017-06-02 Midwestern University Nuevos tratamientos terapéuticos usando centaquina
CA2917325C (en) 2013-07-08 2023-09-05 Midwestern University Compositions and methods for treating neuropsychiatric disorders using an endothelin-b receptor agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
KR910000151A (ko) 1991-01-29
EP0410114A2 (en) 1991-01-30
EP0410114A3 (en) 1992-01-02
HU903291D0 (en) 1990-10-28
TW198681B (ca) 1993-01-21
HU205856B (en) 1992-07-28
CA2017781A1 (en) 1990-12-01
US5055470A (en) 1991-10-08
HUT54050A (en) 1991-01-28
JPH0320222A (ja) 1991-01-29

Similar Documents

Publication Publication Date Title
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
ZA895588B (en) Intravenou pharmaceutical composition and process for preparing the same
HUT62559A (en) Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
IL94525A0 (en) Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders
HUT47113A (en) Process for producing 3-(benzopyrano- and -thiopyrano-pyrazolyl)-3-oxo-propionitriles and pharmaceutical compositions comprising the same
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
NZ228222A (en) 2(substituted-1-tetrahydropyridyl or substituted piperazinyl) propyl: isoindolinone derivatives; preparatory processes and pharmaceutical compositions
GB2232593B (en) Process for improving the therapeutic efficacy of fat-soluble corticosteriods and composition for carrying out this process
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT55407A (en) Process for producing 3'-azido-purine nucleosides and pharmaceutical compositions containing them
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HUT54378A (en) Process for producing squalene-synthetaze inhibitors containing phosphours and pharmaceutical compositions containing them
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HUT58102A (en) Process for producing quinolidine derivatives and pharmaceutical compositions comprising such compounds
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
HUT49115A (en) Process for producing new n-substituted mercapto-propanamides and pharmaceutical compositions containing them
EP0564216A3 (en) Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
ZA843712B (en) 2,6-disubstituted-1,4-dihydropyridine derivative,process for the preparation of the same and pharmaceutical composition comprising the same
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof